RUSSEK-BLUM NIVA enters NEUROSENSE THERAPEUTICS LTD. with 267.95K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/30/2026ACC: 0001213900-26-036429
Officer· Chief Technology Officer
Since Mar 2026
267.95K
Baseline shares
100% direct
267.95K
Direct ownership
4 positions
36K
Derivative underlying
1 instrument
4
Security positions
All direct
Non-Derivative Holdings4
Ordinary Shares
DirectShares owned39.88K
Ordinary Shares
DirectShares owned183.07K
Restricted Share Units
DirectShares owned10K
Ordinary Shares
DirectShares owned35K
Total
267.95K direct267.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 39.88K | Direct |
| Ordinary Shares | 183.07K | Direct |
| Restricted Share Units | 10K | Direct |
| Ordinary Shares | 35K | Direct |
| Total | 267.95K | 267.95K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
36K
Shares owned
N/A
Exercise price
2.18
Expiration
—
Exercise window
—
Total
Underlying
36K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 2.18 | — | — | 36K | N/A |
| Total | 36K | 0.00 | ||||